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Dendritic cells (DC) are the most potent antigen present-
ing cells, because they can internalize, process and present
antigens in order to activate T-cells. Accordingly, DC has
the ability to activate tumour-specific T-cell response.
However, this does not occur in most types of cancer, in
opposite DC even help maintaining tumour tolerance.
Instead of being eliminated by the immune response,
tumours progress and metastasize. This failure of the
immune system is caused by an abnormal DC differentia-
tion and activation mediated through several tumour
derived factors like IL-6 and IL-10. It is well known, that
IL-6 and IL-10 signalling is mainly supported by signal
transducer and activator of transcription 3 (STAT3). The
mechanisms how STAT3 affects the maturation and acti-
vation of DC and which STAT3 target genes are involved
in this process is still unknown.
To understand the modulation of dendritic cell function
by IL-10, gene expression profiling was performed by
using Affymetrix technology in human monocyte-derived
DC treated with IL-10, alone or in combination with LPS.
The regulation of selected genes was validated by real-time
PCR. IL-10 regulated in DC the expression of a limited
number of genes, including IL-7, CD200, DGKA and sig-
nal transduction elements. We have compared the cell
phenotype and functional properties of monocyte/macro-
phage derived dendritic cells which where preincubated
with IL-10 followed by activation through LPS. This com-
bined treatment modulated a number of genes compara-
ble to LPS alone, but differ in their amplitude of
regulation. As expected, IL-10 suppressed the expression
of several LPS-inducible proinflammatory molecules.
Our results deliver insight into, how STAT3 interferes with
maturation and activation of DC and generates immuno-
tolerance towards tumours.
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